~263 spots leftby Apr 2026

Family Support Tool Intervention for Critical Illness

(FST Trial)

Recruiting at6 trial locations
DB
Overseen byDouglas B White, MD, MAS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Pittsburgh
Disqualifiers: No surrogate, Imminent death, Incarcerated, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests a program that helps families of critically ill older adults by offering meetings with doctors and an online tool. It aims to improve communication, help families make informed decisions, and reduce their stress.

Will I have to stop taking my current medications?

The trial protocol does not specify whether participants must stop taking their current medications.

What data supports the effectiveness of the Family Support Tool Intervention (FST) treatment for critical illness?

Research shows that family-centered care interventions in the ICU can improve outcomes, suggesting that the Family Support Tool Intervention may help improve family experiences and reduce stress during critical illness.12345

Is the Family Support Tool Intervention safe for humans?

The available research does not provide specific safety data for the Family Support Tool Intervention, but it generally involves support and communication strategies, which are typically safe for humans.13678

How is the Family Support Tool Intervention unique compared to other treatments for critical illness?

The Family Support Tool Intervention is unique because it focuses on providing structured support to the families of critically ill patients, helping them cope and function better during the crisis, which is not typically addressed by standard medical treatments for critical illness.3691011

Research Team

DB

Douglas B White, MD, MAS

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for critically ill older adults (age ≥60) in the ICU with a high risk of death or severe long-term impairment, and their family surrogates. Patients must lack decision-making capacity and have at least a 50% chance of dying or needing significant help with daily activities. Surrogates must be adults, speak English, able to use the internet, and not involved in conflicting studies.

Inclusion Criteria

Clinician: Patient's primary attending (or their designee)
Up to 3 additional surrogates
I am 50 years old or older.
See 3 more

Exclusion Criteria

Surrogate cannot read or understand English
I have recovered from my previous condition.
My doctor and their team have chosen not to participate.
See 13 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Intervention

Proactive family meetings within 48 hours of enrollment and every 5-7 days thereafter. Family members complete sections of an interactive web-based tool upon study enrollment, before family meetings, and any other time they wish.

6 months
Multiple virtual interactions and in-person meetings

Follow-up

Participants are monitored for patient and family-centeredness of care, functional status, and other outcomes at 3 and 6 months after hospital discharge.

6 months
3-month and 6-month follow-up assessments

Treatment Details

Interventions

  • Multi-component Family Support Intervention (Behavioural Intervention)
Trial OverviewThe study tests if a multi-component family support tool can improve care for ICU patients by scheduling proactive family meetings and providing an interactive web-based tool to prepare families for discussions about patient values, preferences, and needs.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Multi-component Family Support Intervention
Group II: ControlActive Control1 Intervention
Usual ICU care

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+
David Apelian profile image

David Apelian

University of Pittsburgh

Chief Executive Officer since 2019

PhD in Molecular Biology from Rutgers University, MD from the University of Medicine and Dentistry of New Jersey, MBA from Quinnipiac University

Pamela D. Garzone profile image

Pamela D. Garzone

University of Pittsburgh

Chief Medical Officer

PhD in Clinical Science from the University of Pittsburgh

University of North Carolina, Chapel Hill, NC, USA

Collaborator

Trials
2
Recruited
3,200+

VA Pittsburgh Healthcare System

Collaborator

Trials
36
Recruited
15,900+

Pittsburgh VA Medical Center-University Drive

Collaborator

Trials
1
Recruited
1,200+

Oregon Health and Science University

Collaborator

Trials
1,024
Recruited
7,420,000+
John Hunter profile image

John Hunter

Oregon Health and Science University

Chief Medical Officer since 2024

MD, specific details unavailable

Ann Madden Rice profile image

Ann Madden Rice

Oregon Health and Science University

Chief Executive Officer

FACHE certification, extensive leadership experience in academic health centers

Baystate Medical Center

Collaborator

Trials
67
Recruited
44,500+

Peter Banko

Baystate Medical Center

Chief Executive Officer

MBA from Stanford University

Dr. Yvonne Cheung

Baystate Medical Center

Chief Medical Officer since 2024

MD from Columbia University, MPH from Harvard School of Public Health, MBA from University of Massachusetts Amherst

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+
Mary E. Klotman profile image

Mary E. Klotman

Duke University

Chief Executive Officer since 2017

MD from Duke University School of Medicine

Michelle McMurry-Heath profile image

Michelle McMurry-Heath

Duke University

Chief Medical Officer since 2020

MD from Duke University School of Medicine

New York City Health and Hospitals Corporation

Collaborator

Trials
33
Recruited
8,500+

University of North Carolina, Chapel Hill

Collaborator

Trials
1,588
Recruited
4,364,000+
Dr. Peggy P. McNaull profile image

Dr. Peggy P. McNaull

University of North Carolina, Chapel Hill

Chief Medical Officer

MD from Louisiana State University School of Medicine

Dr. Lynne Fiscus profile image

Dr. Lynne Fiscus

University of North Carolina, Chapel Hill

Chief Executive Officer since 2020

MD from Georgetown University, MPH from UNC

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Dr. Richard J. Hodes

National Institute on Aging (NIA)

Chief Executive Officer since 1993

MD from Harvard Medical School

Dr. Marie Bernard

National Institute on Aging (NIA)

Chief Medical Officer

MD from Harvard Medical School

Findings from Research

The nurse-led family support intervention in the intensive care unit was viewed as essential by both families and healthcare staff, enhancing the overall care experience.
This intervention improved communication between staff and families, allowing for better relationship-building and support, indicating its potential value in critical care settings.
Family and health professional experience with a nurse-led family support intervention in ICU: A qualitative evaluation study.Naef, R., Massarotto, P., Petry, H.[2021]
The study identifies specific support interventions that significantly benefit the families of critically ill patients, highlighting the importance of addressing their needs during such challenging times.
It recommends targeted nursing actions to effectively meet the support needs of these families, emphasizing the role of healthcare providers in enhancing family well-being in critical care settings.
Family perceptions of support interventions in the intensive care unit.De Jong, MJ., Beatty, DS.[2019]
The implementation of a standardized family stress screening tool in a pediatric intensive care unit (PICU) led to a significant increase in stress screenings from 0% to 100% over 18 months, ensuring that all families received timely support.
Parent satisfaction regarding emotional support improved significantly, with scores rising from 81.7 to 87.0, and the number of security calls for distressed families decreased by 50%, indicating a reduction in family crises.
Co-designed PICU Family Stress Screening and Response System to Improve Experience, Quality, and Safety.Liaw, KR., Cho, J., Devins, L., et al.[2023]

References

Family and health professional experience with a nurse-led family support intervention in ICU: A qualitative evaluation study. [2021]
Family perceptions of support interventions in the intensive care unit. [2019]
Co-designed PICU Family Stress Screening and Response System to Improve Experience, Quality, and Safety. [2023]
Outcomes of Patient- and Family-Centered Care Interventions in the ICU: A Systematic Review and Meta-Analysis. [2022]
Family-centered outcomes during and after critical illness: current outcomes and opportunities for future investigation. [2020]
Interventions to promote family member involvement in adult critical care settings: a systematic review. [2022]
Does an educational website improve psychological outcomes and satisfaction among family members of intensive care unit patients? [2023]
Family member interventions: research challenges. [2006]
Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU. [2022]
Family Health Conversations create awareness of family functioning. [2020]
Critical health-disease transition in the family: Nursing intervention in the lived experience. [2022]